Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole-genome sequencing expands the mutational spectrum of autism with novel genes, causative CNVs and chromosomal rearrangements

ABSTRACT: Identification of genomic variants from whole-genome sequencing dataset of 32 Chinese trios with autism, including de novo mutations (DNMs), inherited variants, copy number variants (CNVs) and genomic structural variants (SVs).

INSTRUMENT(S): Illumina HiSeq 2000

ORGANISM(S): Homo Sapiens

SUBMITTER: Wenzhou Medical University

PROVIDER: PRJEB14713 | EVA | 2016-07-06

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Similar Datasets

Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation

Project description:Autism spectrum disorder (ASD) and mental retardation (MR) represent clinically distinct neurodevelopmental disorders with a complex genetic etiology. Using microarrays we identified de novo copy number variations in the SHANK2 synaptic scaffolding gene in two unrelated ASD and MR patients; DNA sequencing of SHANK2 revealed additional variants including a de novo nonsense mutation and 7 rare inherited changes. Our findings further link common genes between ASD and intellectual disability.

2010-05-01 | GSE20533 | GEO

Copy number variants in autism spectrum disorders

Project description:Our cohort comprised 40 non-syndromic ASD children.We conducted genome wide analysis using Affymetrix Cytoscan-HD microchips. We identified pathogenic CNVs in 7 patients (17.5%), other variant classified as variants of uncertain significance (VUS) or benign.

2025-04-22 | GSE270110 | GEO

De novo structural variants in autism spectrum disorder disrupt distal regulatory interactions of neuronal genes [Hi-C]

Project description:Three-dimensional genome organization plays a critical role in gene regulation, and disruption of chromatin structure has been shown to lead to developmental disorders through the changed contact between key genes and their distal regulatory elements. Structural variants (SVs) have the ability to disrupt local genome organization, such as the joining of topologically associated domains upon deletion of a boundary. Unfortunately, testing large numbers of SVs for their effects on chromatin structure and gene expression is time and cost prohibitive. To overcome these experimental limitations, we previously developed SuPreMo, a convolutional neural network based method that accurately predicts how sequence variants change genome structure. Here, we extended the tool to specifically measure changed contact at regions of interest, such as cell type specific regulatory elements. Using this updated SuPreMo, we tested hundreds of de novo SVs (dnSVs) from autism spectrum disorder (ASD) individuals and their unaffected siblings and predicted how nearby genes’ regulatory interactions were affected in neurons. We found that putative cis-regulatory element interactions (CREints) are more disrupted by dnSVs from ASD probands versus unaffected siblings, allowing us to prioritize proband CREints of genes involved in neuronal development. We experimentally validated our top locus using induced pluripotent stem cell-derived excitatory neurons with and without the dnSV and found that the variant resulted in mis-regulation of 1102 genes. This in vitro characterization of a candidate causal variant is important, because most ASD patients do not carry a damaging protein-coding variant that alters neurodevelopment or neuronal function. This study establishes disrupted genome folding as a new genetic mechanism for ASD and provides a general strategy for prioritizing variants predicted to disrupt regulatory interactions in any tissue.

2025-12-01 | GSE281283 | GEO

De novo structural variants in autism spectrum disorder disrupt distal regulatory interactions of neuronal genes [RNA-Seq]

2025-12-01 | GSE281327 | GEO

RNA-seq of 36 individuals with autism spectrum disorder

Project description:To assess the clinical impact of splice-altering noncoding mutations in autism spectrum disorder (ASD), we used a deep learning framework (SpliceAI) to predict the splice-altering potential of de novo mutations in 3,953 individuals with ASD from the Simons Simplex Collection. To validate these predictions, we selected 36 individuals that harbored predicted de-novo cryptic splice mutations; each individual represented the only case of autism within their immediate family. We obtained peripheral blood-derived lymphoblastoid cell lines (LCLs) and performed high-depth mRNA sequencing (approximately 350 million 150 bp single-end reads per sample). We used OLego to align the reads against a reference created from hg19 by substituting de novo variants of each individual with the corresponding alternate allele.

2018-11-25 | E-MTAB-7351 | biostudies-arrayexpress

A novel approach for simultaneous detection of structural and single-nucleotide variants based on a combination of chromosome conformation capture and exome sequencing

Project description:Effective molecular diagnosis of congenital diseases hinges on comprehensive genomic analysis, traditionally reliant on various methodologies specific to each variant type — whole exome or genome sequencing for single nucleotide variants (SNVs), array CGH for copy-number variants (CNVs), and microscopy for structural variants (SVs). We introduce a novel, integrative approach combining exome sequencing with chromosome conformation capture, termed Exo-C. This method enables the concurrent identification of SNVs in clinically relevant genes and SVs across the genome and allows analysis of heterozygous and mosaic carriers. Enhanced with targeted long-read sequencing, Exo-C evolves into a cost-efficient solution capable of resolving complex SVs at base-pair accuracy. Through several case studies, we demonstrate how Exo-C's multifaceted application can effectively uncover diverse causative variants and elucidate disease mechanisms in patients with rare disorders.

2024-01-24 | GSE253950 | GEO

Array-CGH in children with intellectual disabilities, developmental delays, autism spectrum disorders and multiple congenital abnormalities

Project description:This study includes the whole-genome screening of unbalanced chromosomal rearrangements (copy-number variants; CNV) in children with ID/DD, ASD and MCA. We identified a broad range of pathogenic/likely pathogenic CNVs as well as variants of unclear significance and likely benign variants. Our results confirm the benefit of array-CGH in the current clinical genetic diagnostics through the identification of genetic cause of ID/DD in the high proportion of affected children.

2019-08-31 | E-MTAB-7696 | biostudies-arrayexpress

Array-CGH in children with intellectual disabilities, developmental delays, autism spectrum disorders and multiple congenital abnormalities

2019-08-31 | E-MTAB-8044 | biostudies-arrayexpress

Targeted next-generation sequencing in children with intellectual disabilities, autism spectrum disorders and multiple congenital abnormalities

Project description:We performed a targeted NGS using the commercial gene panel design ClearSeq Inherited Disease (Agilent Technologies) to identify the pathogenic sequence variants in children with ID/DD, ASD and MCA and their unaffected parents

2019-08-31 | E-MTAB-8041 | biostudies-arrayexpress

Array-CGH in children with intellectual disabilities, developmental delays, autism spectrum disorders and multiple congenital abnormalities, dataset 1

2019-04-30 | E-MTAB-6685 | biostudies-arrayexpress